HaemSTAR is a network of clinical hematology registrars within the UK that aims to promote clinical research in non-malignant hematology. The disparity in the number of research studies, treatment options and amount of research funding for non-malignant hematology compared with malignant hematology requires addressing. Here, HaemSTAR Co-lead Pip Nicolson, MA, MB BChir (Cantab), MRCP (UK), from the University of Birmingham, Birmingham, UK, explains the different ways in which HaemSTAR aims to promote clinical research for non-malignant hematology. Dr Nicolson emphasizes the importance of increasing the involvement of registrars in clinical trials to increase overall research activity. This video was recorded at the British Society for Haematology (BSH) 2018 Annual Meeting in Liverpool, UK.
HaemSTAR: promoting clinical research in non-malignant hematology
